BIOHARVEST SCIENCES INC.
BHST evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for BHST—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper AI · BHST
BioHarvest Sciences Inc. (BHST) is a biotechnology company based in Vancouver, Canada, focused on developing and commercializing botanical-based products. As of its latest financial report (2025-12-31), the company reported $34.5M in revenue and a net loss of $11.1M.
Key risk: Negative net income
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Financial data as of Dec 31, 2025.
BioHarvest Sciences Inc. (BHST) is a biotechnology company based in Vancouver, Canada, focused on developing and commercializing botanical-based products. As of its latest financial report (2025-12-31), the company reported $34.5M in revenue and a net loss of $11.1M.
- Cash and equivalents of $23.0M as of 2025-12-31 [sec].
- Total revenue of $34.5M for the period ending 2025-12-31 [sec].
- Net loss of $11.1M for the period ending 2025-12-31 [sec].
- Shareholders' equity of $1.3M as of 2025-12-31 [sec].
- Total debt of $10.3M as of 2025-12-31 [sec].
What works
- Revenue generation of $34.5M indicates commercial activity and market presence [sec].
- Cash position of $23.0M provides a liquidity buffer for operations and development [sec].
What to weigh
- Net loss of $11.1M reflects ongoing operational expenses exceeding revenue [sec].
- Shareholders' equity of $1.3M is low relative to total debt of $10.3M, indicating a leveraged balance sheet [sec].
Risks & what to watch (2)›
Key risks
- Negative net income — The company reported a net loss of $11.1M as of 2025-12-31, indicating ongoing unprofitability [sec].
- High debt relative to equity — Total debt of $10.3M exceeds shareholders' equity of $1.3M as of 2025-12-31, suggesting financial leverage risk [sec].
What to watch
- Future revenue growth and path to profitability [sec].
- Ability to manage debt and improve equity position [sec].
- Any new product developments or regulatory milestones [sec].
Sources: SEC filings · Generated August 25, 2026 · How we verify sources →
Run BIOHARVEST SCIENCES INC. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available BIOHARVEST SCIENCES INC. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Evidence & data
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
10.5 months
OCF -$7M · Net income -$11M
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Runway
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
15
Total value held
$3.9M
| Holder | Shares | Value |
|---|---|---|
| alyeska investment group, l.p. | 757,064 | $3.3M |
| king luther capital management corp | 40,000 | $174K |
| xtx topco ltd | 29,649 | $129K |
| susquehanna international group, llp | 16,394 | $71K |
| citadel advisors llc | 14,753 | $64K |
| jane street group, llc | 13,083 | $57K |
| geode capital management, llc | 11,811 | $51K |
| vident advisory, llc | 11,576 | $50K |
| morgan stanley | 3,250 | $14K |
| royal bank of canada | 3,009 | $13K |
Showing top 10 of 15 institutional holders of BIOHARVEST SCIENCES INC.. Open the full 13F history after sign-in.
Short Interest
as of May 20, 2026- % of float
- 0.3%
- Days to cover
- 2.2
- Shares short
- 64,823
- Daily short volume (Aug 4, 2026)
- 8.4%
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
BHST short interestFrequently asked questions
What is the AI investment thesis for BIOHARVEST SCIENCES INC.?
BioHarvest Sciences Inc. (BHST) is a biotechnology company based in Vancouver, Canada, focused on developing and commercializing botanical-based products. As of its latest financial report (2025-12-31), the company reported $34.5M in revenue and a net loss of $11.1M.
Who is the CEO of BIOHARVEST SCIENCES INC.?
Dr. Zaki Rakib Ph.D. is the chief executive officer of BIOHARVEST SCIENCES INC. (BHST).
Where is BIOHARVEST SCIENCES INC. headquartered?
BIOHARVEST SCIENCES INC. (BHST) is headquartered in Vancouver, BC, Canada.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.